JP2021533728A5 - - Google Patents

Info

Publication number
JP2021533728A5
JP2021533728A5 JP2020551897A JP2020551897A JP2021533728A5 JP 2021533728 A5 JP2021533728 A5 JP 2021533728A5 JP 2020551897 A JP2020551897 A JP 2020551897A JP 2020551897 A JP2020551897 A JP 2020551897A JP 2021533728 A5 JP2021533728 A5 JP 2021533728A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
composition according
solubil
gram
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020551897A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021533728A (ja
Filing date
Publication date
Priority claimed from PCT/US2019/024912 external-priority patent/WO2019191633A2/en
Application filed filed Critical
Priority claimed from PCT/US2019/047916 external-priority patent/WO2020046747A1/en
Publication of JP2021533728A publication Critical patent/JP2021533728A/ja
Publication of JP2021533728A5 publication Critical patent/JP2021533728A5/ja
Priority to JP2024098623A priority Critical patent/JP2024123123A/ja
Pending legal-status Critical Current

Links

JP2020551897A 2018-08-23 2019-08-23 溶解素−抗微生物ペプチド(amp)ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用 Pending JP2021533728A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024098623A JP2024123123A (ja) 2018-08-23 2024-06-19 溶解素-抗微生物ペプチド(amp)ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201862721969P 2018-08-23 2018-08-23
US62/721,969 2018-08-23
US201862722793P 2018-08-24 2018-08-24
US62/722,793 2018-08-24
USPCT/US2019/024912 2019-03-29
PCT/US2019/024912 WO2019191633A2 (en) 2018-03-29 2019-03-29 Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
US201962849320P 2019-05-17 2019-05-17
US62/849,320 2019-05-17
US201962860836P 2019-06-13 2019-06-13
US62/860,836 2019-06-13
PCT/US2019/047916 WO2020046747A1 (en) 2018-08-23 2019-08-23 Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024098623A Division JP2024123123A (ja) 2018-08-23 2024-06-19 溶解素-抗微生物ペプチド(amp)ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用

Publications (2)

Publication Number Publication Date
JP2021533728A JP2021533728A (ja) 2021-12-09
JP2021533728A5 true JP2021533728A5 (cg-RX-API-DMAC7.html) 2022-08-22

Family

ID=69643049

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020551897A Pending JP2021533728A (ja) 2018-08-23 2019-08-23 溶解素−抗微生物ペプチド(amp)ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用
JP2024098623A Pending JP2024123123A (ja) 2018-08-23 2024-06-19 溶解素-抗微生物ペプチド(amp)ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024098623A Pending JP2024123123A (ja) 2018-08-23 2024-06-19 溶解素-抗微生物ペプチド(amp)ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用

Country Status (10)

Country Link
US (2) US20210363511A1 (cg-RX-API-DMAC7.html)
EP (1) EP3840771A4 (cg-RX-API-DMAC7.html)
JP (2) JP2021533728A (cg-RX-API-DMAC7.html)
KR (1) KR20210049023A (cg-RX-API-DMAC7.html)
CN (1) CN112292143A (cg-RX-API-DMAC7.html)
AU (1) AU2019327378A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020018787A2 (cg-RX-API-DMAC7.html)
IL (2) IL313959A (cg-RX-API-DMAC7.html)
MX (1) MX2020010076A (cg-RX-API-DMAC7.html)
WO (1) WO2020046747A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016030580B1 (pt) * 2014-06-26 2023-12-19 The Rockefeller University Polipeptídeo de lisina e fragmento de polipeptídeo com atividade para matar bactérias gram-negativas
BR112020011433A2 (pt) 2017-12-12 2020-12-01 Contrafect Corporation identificação de lisinas e seus derivados com atividade bacteriana contra pseudomonas aeruginosa
WO2019191633A2 (en) * 2018-03-29 2019-10-03 Contrafect Corporation Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
MX2020010071A (es) * 2018-03-29 2021-01-08 Contrafect Corp Polipeptidos anti-microbianos, derivados de bacteriofago, y sus usos contra bacterias gram negativas.
MX2021012166A (es) * 2019-04-05 2021-11-03 Contrafect Corp Lisinas y sus derivados con actividad bactericida contra pseudomona aeruginosa, en la presencia de suero humano.
MX2021015563A (es) * 2019-07-05 2022-03-17 Contrafect Corp Polipéptidos anti-microbianos, derivados de bacteriófago, y sus usos contra bacterias gramnegativas y acidorresistentes.
WO2021211303A1 (en) * 2020-04-14 2021-10-21 Contrafect Corporation Antiviral, bacteriophage-derived polypeptides and their use against viruses
CN112251454B (zh) * 2020-10-30 2023-01-20 西南大学 一种抗沙门氏菌噬菌体表达的内溶酶和穿孔素组合物及其制备方法和应用
CN113025640B (zh) * 2021-03-17 2023-09-12 天康生物制药有限公司 一种布鲁氏菌外膜囊泡的制备方法及其应用
FR3149205B1 (fr) * 2023-06-02 2026-04-24 Oreal Composition cosmétique comprenant une endolysine et un agent de charge organique
WO2024256710A2 (en) 2023-06-15 2024-12-19 Aurobac Therapeutics Sas Engineered lysin polypeptide constructs active against gram-negative bacteria

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120135917A1 (en) * 2009-06-16 2012-05-31 Eisaku Yoshihara Anti-Gram Negative Bacteria Agent
PL2445515T3 (pl) * 2009-06-26 2016-10-31 Środki przeciwdrobnoustrojowe
US20120195872A1 (en) * 2009-06-26 2012-08-02 Lysando Ag Antimicrobial agents
US20140120074A1 (en) * 2011-04-27 2014-05-01 Lysando Ag Antimicrobial agents
BR112016030580B1 (pt) * 2014-06-26 2023-12-19 The Rockefeller University Polipeptídeo de lisina e fragmento de polipeptídeo com atividade para matar bactérias gram-negativas
ES2934714T3 (es) * 2015-09-17 2023-02-24 Contrafect Corp Polipéptidos de lisina activos contra bacterias Gram-negativas
KR102000120B1 (ko) * 2017-01-26 2019-07-15 주식회사 코미팜 이유 자돈의 대장균증을 예방하기 위한 재조합 p22 라이소자임 - pmap36 융합 단백질을 이용한 장내독소형 대장균(etec) 고스트 백신 조성물
BR112020011433A2 (pt) * 2017-12-12 2020-12-01 Contrafect Corporation identificação de lisinas e seus derivados com atividade bacteriana contra pseudomonas aeruginosa
US10988520B2 (en) * 2018-03-29 2021-04-27 Contrafect Corporation Lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
WO2019191633A2 (en) * 2018-03-29 2019-10-03 Contrafect Corporation Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof

Similar Documents

Publication Publication Date Title
IL313959A (en) Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
JP2021519083A5 (cg-RX-API-DMAC7.html)
US12144845B2 (en) Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
Memariani et al. Antibiofilm properties of cathelicidin LL-37: an in-depth review
Shahrour et al. AMPs as anti-biofilm agents for human therapy and prophylaxis
IL277119B2 (en) Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
JP5964854B2 (ja) 抗菌剤と分散剤または接着阻害剤組成物
RU2020133461A (ru) Предотвращение, разрушение и обработка биопленки лизином бактериофага
JP2024010053A5 (cg-RX-API-DMAC7.html)
JP2022163214A5 (cg-RX-API-DMAC7.html)
Blanchette et al. Current therapies in treatment and prevention of fracture wound biofilms: why a multifaceted approach is essential for resolving persistent infections
Khan et al. Antibiotics application strategies to control biofilm formation in pathogenic bacteria
JP2021519311A5 (cg-RX-API-DMAC7.html)
CN101511430A (zh) 抗生素组合物
JP2023502940A5 (cg-RX-API-DMAC7.html)
JP2023523319A5 (cg-RX-API-DMAC7.html)
Jalil et al. The use of combination therapy for the improvement of colistin activity against bacterial biofilm
RU2020112725A (ru) Композиции и способы для борьбы с инфекциями, вызванными синегнойной палочкой (pseudomonas aeruginosa)
JP2016504411A (ja) 細菌感染を処置するための組成物および方法
JP2022526978A5 (cg-RX-API-DMAC7.html)
RU2020129478A (ru) Полипептидные конструкции лизин-противомикробный пептид (amp), лизины, выделенные полинуклеотиды, кодирующие их, а также варианты их применения
HK40086790A (en) Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
RU2021128336A (ru) Лизины и их производные с бактерицидной активностью против pseudomonas aeruginosa в присутствии сыворотки крови человека
RU2020118691A (ru) Идентификация лизинов и их производных, обладающих антибактериальной активностью против pseudomonas aeruginosa
Jain et al. Stopping the Unstoppable: Unconventional Methods to Prevent the Biofilm Growth